CAPTRUST Financial Advisors
DWTX

CAPTRUST Financial Advisors’s Dogwood Therapeutics DWTX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,606
Closed -$170K – 4159
2022
Q2 		$170K Hold
1,606
– – ﹤0.01% 1816
2022
Q1 		$180K Hold
1,606
– – ﹤0.01% 1802
2021
Q4 		$205K Hold
1,606
– – ﹤0.01% 1623
2021
Q3 		$212K Buy
+1,606
New +$222K ﹤0.01% 1518

Other funds holding DWTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CAPTRUST Financial Advisors's DWTX Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Dogwood Therapeutics (DWTX) in Q3 2022, closing a stake of 1,606 shares — an estimated $170K sold.

CAPTRUST Financial Advisors first reported a position in DWTX in Q3 2021 and held it in 4 quarters. The position peaked at $212K in Q3 2021. 25 funds tracked by Wall St. Rank hold DWTX as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Dogwood Therapeutics position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,606 Dogwood Therapeutics shares in Q3 2022, an estimated $170K.
  • CAPTRUST Financial Advisors first reported a position in Dogwood Therapeutics in Q3 2021 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's Dogwood Therapeutics position peaked at $212K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.